Cartiva Toe Implant Lawsuit MDL 3172 2026: Do You Qualify to File?

Do You Qualify for a Cartiva Toe Implant Lawsuit?

Here’s the short answer: if you had a Cartiva Synthetic Cartilage Implant placed in your big toe joint and later dealt with subsidence, implant fragments, persistent pain, or a second surgery to remove it and fuse the joint, you have a case worth evaluating. That second surgery, in particular, is exactly the kind of documented harm that carries weight in a product liability claim.

The core problem driving this litigation is straightforward. Cartiva was marketed as a way to treat big toe arthritis without giving up joint motion, a genuine upgrade over the older standard of care, fusion surgery, which locks the joint permanently. A meaningful number of patients who got the implant ended up back at fusion anyway, after a failed device and a second operation they were told they could avoid. That gap between the promise and the outcome is the heart of every complaint filed so far.

Two things happened that changed the landscape for people affected: Stryker recalled the device in late 2024, and in early 2026 the federal Judicial Panel on Multidistrict Litigation consolidated the growing number of federal cases into MDL No. 3172 in the Eastern District of Arkansas. Neither of those events means a payout is guaranteed or imminent, and this piece won’t pretend otherwise, but they do mean the legal infrastructure now exists to pursue a claim efficiently instead of filing a lone case against a major device manufacturer.

What follows is a working guide: what the device is, what injuries are showing up, how the MDL process actually unfolds, what to document, and the mistakes that quietly weaken otherwise solid claims.

---

What Is the Cartiva Implant, and Why Did So Many Surgeons Recommend It?

The Cartiva Synthetic Cartilage Implant (SCI) is a small hydrogel device implanted into the first metatarsophalangeal joint, the joint at the base of the big toe, to treat hallux rigidus, a degenerative arthritis of that joint that makes every step painful. It earned FDA premarket approval in 2016 and was pitched to both surgeons and patients as a motion-preserving alternative to the traditional fix, MTP fusion.

That pitch mattered clinically. Fusion works reliably to eliminate pain, but it permanently stiffens the joint, which changes gait mechanics and can be a hard sell to active patients: runners, hikers, people who simply don’t want a fused toe in their 50s. Cartiva offered a version of “fix the pain, keep the motion,” and that’s exactly why it became popular with orthopedic and podiatric surgeons treating an active patient population.

A brief ownership history matters for the lawsuit: Cartiva Inc. originally developed and sold the device. Wright Medical Group later acquired the product line, and Stryker Corporation acquired Wright Medical in 2020. Stryker is now the manufacturer of record, the party that issued the 2024 recall, and the primary defendant across the consolidated litigation. By manufacturer estimates, more than 20,000 patients in the U.S. received a Cartiva implant before the recall took the device off the market.

For context on how a similar gap between a manufacturer’s stated safety data and real-world outcomes plays out in litigation, see how that dynamic unfolded in the Valsartan NDMA cancer lawsuit, another case built on the distance between what a product was sold as and what it actually delivered.

---

What Injuries Are Cartiva Patients Actually Reporting?

The gap between clinical trial data and real-world results is the engine of this litigation. The original FDA approval trial reported a five-year revision rate in the single digits. Independent peer-reviewed follow-up studies conducted after the device reached the broader market reported materially higher failure and revision rates in real patients, a discrepancy plaintiffs’ attorneys argue Stryker either knew about or should have identified sooner through post-market surveillance.

Reported Issue	What It Looks Like	Typical Next Step
Subsidence	Implant sinks into the surrounding bone, causing instability and pain	Imaging follow-up, possible removal
Migration/displacement	Implant shifts out of position, causing friction and joint irritation	Removal if symptomatic
Fragmentation	Implant material breaks apart inside the joint, triggering a foreign-body/synovitis reaction	Arthroscopic debridement or removal
Chronic or worsening pain	Pain persists or returns after the initial post-op recovery window	Ongoing management, imaging, specialist referral
Nerve-related symptoms	Numbness, tingling, or localized nerve pain near the joint	Podiatry/orthopedic evaluation
Revision converted to fusion	Removal surgery ends with the joint fused after all	Extended rehab, altered gait pattern

That last row is the one plaintiffs’ attorneys keep returning to. In one published follow-up study, a large majority of patients who needed revision surgery, cited at roughly 70%, ended up with a full joint fusion, meaning they underwent the exact procedure Cartiva was marketed to help them avoid, plus a second recovery on top of the first. That’s the practical injury at the center of most Cartiva complaints: not just device failure, but the loss of the specific benefit the device was sold on.

---

Why Was Cartiva Recalled, and What Is MDL 3172?

Stryker issued a recall of the Cartiva Synthetic Cartilage Implant in late 2024. The stated basis combined a rising volume of adverse event reports filed with the FDA’s device-reporting database and independent clinical studies showing subsidence, fragmentation, and revision rates well above what the original approval trial had reported.

Once the recall became public, lawsuits started landing in federal courts around the country. Enough of them were filed against the same defendant over the same core allegations that, in early 2026, the Judicial Panel on Multidistrict Litigation (JPML) centralized the federal cases into a single proceeding: In re: Cartiva Synthetic Cartilage Implant Products Liability Litigation, MDL No. 3172, assigned to Judge Kristine G. Baker in the U.S. District Court for the Eastern District of Arkansas. Initial organizational proceedings were underway through mid-2026.

One clarification worth making explicitly: an MDL is not a class action. Your case remains your case. It gets consolidated for shared pretrial work (discovery, expert testimony on general causation, motion practice), but any eventual settlement or verdict is calculated based on your specific injuries, medical history, and damages, not split evenly among everyone in the litigation.

For a look at how a different kind of mass litigation moves from scattered individual filings toward coordinated proceedings, the Eaton and Palisades fire Edison lawsuit shares the same basic structural mechanics, even though the underlying facts couldn’t be more different.

---

How Does the Cartiva MDL Actually Move Forward From Here?

Medical device MDLs follow a fairly predictable rhythm, even though the exact calendar depends on court orders and can shift. Here’s the general shape of what comes next, based on how comparable device MDLs have unfolded.

Stage	What Happens	What You Need to Do
1. Transfer & organization	JPML consolidates cases; plaintiffs’ steering committee (PSC) is appointed	Retain counsel, get your case filed and registered
2. Initial discovery	Manufacturer’s internal documents, trial data, and marketing materials get produced	Submit your medical and surgical records
3. General causation hearings	Experts testify on whether the device can cause the alleged injuries	Cooperate with any independent medical exam if required
4. Bellwether trial selection	A small set of representative cases is chosen and tried to help value the litigation	Cooperate if your case is selected as a bellwether
5. Settlement negotiations (or individual trials)	Bellwether outcomes typically shape settlement talks for the broader group	Keep your damages documentation current
6. Resolution	Settlement, or remand to your home court for individual trial	Final review and sign-off on any resolution

Right now, the litigation sits at roughly stages one and two. Bellwether trials and any organized settlement program are typically years away in device MDLs of this size. Anyone promising a fast payout is not describing how this actually works. The more urgent risk isn’t a slow process; it’s missing your own filing deadline while waiting to see what happens next.

---

Do You Meet the Eligibility Checklist?

Use this as a starting point, not a final answer. An attorney still needs to confirm eligibility against your state’s law and your actual records.

Checklist Item	Check
You had a Cartiva Synthetic Cartilage Implant placed in a U.S. hospital or surgery center	Yes / No
You experienced subsidence, migration, fragmentation, or unresolved pain after implantation	Yes / No
You’ve had, or are actively considering, removal and/or revision-to-fusion surgery	Yes / No
Your diagnosis or revision surgery falls within your state’s statute-of-limitations window	Yes / No
You have (or can request) surgical notes, imaging, and follow-up records	Yes / No
You incurred added medical costs, rehab expenses, or lost work time from the complication	Yes / No

If most of these apply to you, there’s no real downside to getting a free case evaluation now. If you received the implant but have no symptoms, you’re not a candidate today, but it’s worth staying on top of routine imaging to catch silent subsidence early.

---

What Evidence Should You Gather Before You Call a Lawyer?

Cartiva cases, like most device litigation, live or die on documentation. Start pulling these together as early as possible:

• Complete surgical records from the original implant procedure, including the device lot or serial number if it’s documented anywhere in your chart
• All imaging — X-rays, CT, or MRI — from right after implantation through your most recent follow-up, plus the radiologist’s reports
• Revision or removal surgery records, specifically noting the reason for removal and whether the joint was fused
• A symptom timeline — when pain started, how it progressed, what it stopped you from doing
• Medical bills and receipts for office visits, imaging, physical therapy, and any assistive devices
• Wage-loss documentation if the complication caused missed work or reduced hours

Weak documentation is one of the fastest ways a legitimate claim gets undervalued. Attorneys use these records to build causation and damages, and gaps in the paper trail become gaps in your leverage.

---

How Much Time Do You Actually Have to File?

The statute of limitations is the single most misunderstood part of this process, and it’s not something to guess at. Every state sets its own deadline for product liability claims, generally somewhere between two and four years, and most apply a discovery rule — meaning the clock typically starts when you knew, or reasonably should have known, that the implant caused your injury, not necessarily the date of your original surgery.

That rule cuts both ways. If your implant surgery was years ago but you only recently connected your ongoing pain or a new diagnosis to the device, your window may well still be open. If you’ve known about the problem for a while and kept putting off a consult, you could be closer to the deadline than you think. Either way, this is not a calculation to make on your own. Get the specific facts of your surgery and symptom timeline in front of an attorney and let them run the clock for you.

---

What Does It Actually Cost to Hire a Cartiva Lawyer?

Nearly every attorney handling Cartiva cases works on a contingency fee basis: no retainer, no hourly billing, and no fee at all unless you recover compensation.

Typical structures look like this:

• Cases resolved through the MDL or a group settlement program: roughly 33% to 40%
• Cases that go to an individual trial: fees can run higher
• Case expenses (expert witnesses, record retrieval, court costs) are usually deducted separately from the settlement

Before signing anything, ask one specific question: are costs deducted before or after the contingency percentage is calculated? That order affects your net recovery more than people expect, and it’s a completely reasonable thing to ask a prospective attorney during a free consultation. That same instinct to read the fine print before committing applies broadly any time you’re signing a consumer-facing legal contract under pressure. It’s the same habit that saves people money in a timeshare exit and cancellation negotiation, where vague fee language causes just as much regret after the fact.

Medical bills piling up while you wait for resolution is a real source of stress for a lot of claimants, and it’s worth being deliberate about how you manage that gap financially rather than letting anxiety drive spending decisions. The kind of pattern covered in managing emotional spending under financial stress is genuinely relevant here, even outside the investing context it’s usually framed in.

---

What Mistakes Quietly Sink Otherwise Strong Cartiva Claims?

Waiting too long because the symptoms “aren’t bad enough yet.” People routinely delay a consultation because they haven’t had revision surgery. Most initial consultations are free, and waiting doesn’t strengthen your case — it just burns statute-of-limitations time.

Assuming the hospital will keep your records forever. Retention policies vary, and if your original implant surgery and your revision surgery happened at different facilities, you need to request records from both separately, and early.

Deciding your own case is “too minor” to pursue. That’s a medical and legal judgment call, not something to self-diagnose out of. Let an attorney and, if needed, a medical expert make that assessment.

Signing with the first firm that calls after seeing a TV ad, without comparing terms. Contingency percentages, cost-deduction order, and firm experience with device MDLs specifically can vary. A short comparison call with a second firm costs you nothing.

Trusting a specific “average settlement” figure floating around online or in a Facebook group. MDL 3172 hasn’t reached bellwether trials. Anyone quoting a precise average payout right now is guessing, or selling something. Check the official MDL docket and your own attorney for real status updates instead.

Between the medical bills, the missed work, and the uncertainty of a multi-year legal process, it’s also worth having a real plan for cash flow while your case works through the system — the same principles covered in a debt consolidation guide can help you avoid compounding the financial strain of an unexpected second surgery with high-interest debt in the meantime.

---

This article is for general informational purposes only and is not legal or medical advice. If you’re experiencing symptoms related to a Cartiva implant, talk to your treating physician. Whether you have a viable legal claim, and how much time you have to file it, depends on the law of your specific state. Consult a licensed attorney in your jurisdiction for guidance on your individual situation. Nothing here guarantees any particular outcome or settlement amount; confirm current MDL status through official court records.